ftInvstr
BALAXI · Healthcare ₹24.93 -1.93% Mkt Cap ₹137 Cr
← Search another stock

BALAXI

Healthcare Drug Manufacturers - Specialty & Generic
★ Watchlist ⧉ Add to bucket
₹24.93
-1.93% today · 30d +2.97%
as of 2026-09-04
Price · Daily Candles
AI narrative is temporarily unavailable for BALAXI. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2025-12-31
REVENUE
₹73 Cr
-1.02% YoY
NET PROFIT
₹0 Cr
-94.31% YoY
OPM
4.38%
-5.88pp YoY
EPS
₹0.06
PE 53.87
Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-26.5% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.
◇ Sector Position
PEERPEROCE %
BALAXI53.8713.0
SUNPHARMA37.5721.44
DIVISLAB89.1821.56
ZYDUSLIFE24.6424.22
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
48
SCORE / 100
Overall
6-axis composite of the sections below.
Performance UNDERPERFORMER 5
Valuation STRETCHED 20
Growth STRONG 70
Profitability AVERAGE 45
Technicals NEUTRAL 58
Risk LOW 90
Key Stats
TTM PE
53.87
P/B
0.54
52W HIGH
₹49.65
OFF HIGH
-49.79%
MKT CAP
₹137 Cr
◉ Active Signals
MACDBullish0.2715
RSI(14)Bullish60.05
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold BALAXI and at what entry.

Sign up freeSign in
AI-generated research based on publicly available data and ftInvstr's bias-safe quantitative models. Not investment advice. Past performance does not guarantee future results. Consult a SEBI-registered investment adviser before making any investment decision.